Discusses American biomedicine's approach to informed consent and end of life issues, such as with cancer diagnoses, with a focus on patient disclosure and cross-cultural issues.
No takes yet. Share an insight, caveat, or question.
Lucy M. Candib (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: